Lord, Abbett & Co’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
2025
Q2
$4.77M Buy
2022
Q2
Sell
2022
Q1
$37.7M Buy
2015
Q4
Sell
2015
Q3
$2.06M Sell
2015
Q2
$8.18M Buy